Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1479869793db47bdb0d75428fd31fd79 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_62badb7fde264b2f81def0b131ce1bbf http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca3ce96363d76f666bddb94aec9c995 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ccdcccdf24f64c32ef6eb43b4369768 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9d39e67a2a5ecca7b5dfca343baf4d4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7abe0507df3ab4b3a5512544a7f33d9c |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-25 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-124 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0602 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0639 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0784 |
filingDate |
2008-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fad31e10e9ba24712a51eeb97e595a3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf040a91e4b937ad52aef70588559333 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f6ee13b0b7af3e1fce4a26e86128d3d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a75eb7a97bbcf1ea1a3dec00f02f7bf1 |
publicationDate |
2009-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2009008666-A2 |
titleOfInvention |
Autologous dendritic cell mediated by photodynamic therapy having the ability to suppress the growth of tumor |
abstract |
The present invention relates to mature dendritic cells (DCs) having the enhanced ability to induce anti-tumor immune responses, and to a method for the preparation of the above-mentioned DCs through the procedure of pulsing immature DCs with lysates of cancer cells on which photodynamic therapy (PDT) has been conducted. The dendritic cell of this invention acquires an activity to induce anti-tumor immune responses so that it exerts a remarkable effect to suppress the growth of tumor. |
priorityDate |
2007-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |